Impact of Genetic Mutations and Health Plan Access to Therapies on Treatment Response and Drug Costs Related to Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myelogenous Leukemia
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Elias Jabbour Melissa Lingohr-Smith |
| Publication date | November 17, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |